Share on LinkedInShare on LinkedIn

ARTICLE · 09 JANUARY 2025

New ANDA Cases

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act.

United StatesIntellectual Property

Federal district court cases that are filed pursuant to the Hatch-Waxman Act

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are filed pursuant to the Hatch-Waxman Act. It also includes the same information for proceedings before the Patent Trial and Appeal Board concerning Orange Book-listed patents.

Case Name Date Filed Judge Drug Patent No(s).
Novo Nordisk Inc. v. Mylan Pharms. Inc., 24-0775 (D. Del.) Jul 1, 2024 Hon. Colm F. Connolly Ozempic® (semaglutide subcutaneous solution) 8,129,343
10,335,462
Currax Pharms. LLC v. Taro Pharm. Indus. Ltd., 24-7446 (D.N.J.) 1-Jul-24

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from